Abstract
Acute pancreatitis is a common cause of hospitalization and a major source of morbidity worldwide. When it is severe, and especially when it progresses to include necrosis of the pancreas, the risk of infection rises and mortality increases. Early reports suggested prophylactic antibiotics given in severe pancreatitis prevent infection and death. More recent clinical trials do not support this benefit, and meta-analyses on the topic offer conflicting recommendations. In this article, we evaluate the body of published literature examining the use of antibiotics as a preventive measure in acute pancreatitis. The highest quality, currently available data fail to support prophylactic use of antibiotics, which should be added to treatment regimens only where infection has been proven.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
DeFrances CJ, Hall MJ. 2005 National hospital discharge survey. Adv Data. 2007;385:1–19.
Froussard JL, Steer ML, Pastor CM. Acute pancreatitis. Lancet. 2008;371:143–52.
Fagenholz PJ, Castillo CF, Harris NS, et al. Increasing United States hospital admissions for acute pancreatitis, 1988–2003. Ann Epidemiol. 2007;17:491–7.
Munsell MA, Buscaglia JM. Acute pancreatitis. J Hosp Med. 2010;5:241–50.
Gupta K, Wu B. In the clinic: acute pancreatitis. Ann Int Med. 2010, 153:ITC5-1to16.
Gaisano HY, Gorelik FS. New insights in to the mechanisms of pancreatitis. Gastroenterology. 2009;136:2040–4.
Park DH, Kim MH, Chari ST. Recent advances in autoimmune pancreatitis. Gut. 2009;58:1680–9.
Khan AS, Latif SU, Eloubeidi MA. Controversies in the etiologies of acute pancreatitis. JOP J Pancreas (Online). 2010;11:545–52.
Acute Pancreatitis Classification Working Group: Revision of the Atlanta classification of acute pancreatitis (3rd revision). Available at www.pancreasclub.com/resources/AtlantaClassification.pdf
Greer SE, Burchard KW. Acute pancreatitis and critical illness: a tale of hypoperfusion and inflammation. Chest. 2009;136:1413–9.
Bai Y, Gao J, Zou DW, et al. Prophylactic antibiotics cannot reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: evidence from a meta-analysis of randomized controlled trials. Am J Gastroenterol. 2008;103:104–10.
Modifi R, Patil PV, Suttie SA, et al. Risk assessment in acute pancreatitis. Br J Surg. 2009;96:137–50.
Gan SI, Romagnuulo J. Admission hematocrit: a simple, useful and early predictor of severe pancreatitis. Dig Dis Sci. 2004;49:1946–52.
Martınez J, Johnson CD, Sanchez-Paya J, et al. Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology. 2006;6:206–9.
Brown A, James-Stevenson T, Dyson T, et al. The Panc 3 score: a rapid and accurate test for predicting severity on presentation in acute pancreatitis. J Clin Gastroenterol. 2007;41:855–8.
Petrov MS, van Santvoort HC, Besselink MGH, et al. Enteral nutrition and the risk of mortality and infectious complications in patients with severe acute pancreatitis: a meta-analysis of randomized trials. Arch Surg. 2008;143:1111–7.
Wu XM, Ji KQ, Wang HY, et al. Total enteral nutrition in prevention of pancreatic necrotic infection in severe acute pancreatitis. Pancreas. 2010;39:248–51.
Stamatakos M, Stefanaki C, Kontzoglou K, et al. Walled-off pancreatic necrosis. World J Garoenterol. 2010;16:1707–12.
van Santvoort HC, Bessleink MG, de Vries AC, et al. Early endoscopic retrograde cholangiopancreatography in predicted severe acute biliary pancreatitis: a prospective multicenter study. Ann Surg. 2009;250:68–75.
Zhang MM, Cheng JQ, Lu YR, et al. Use of pre-, pro- and synbiotics in patients with acute pancreatitis: a meta-analysis. Wold J Gastroenterol. 2010;16:3970–8.
Craig RM, Dordal E, Myles L. The use of ampicillin in acute pancreatitis [letter]. Ann Intern Med. 1975;83:831–2.
Howes R, Zuidema GD, Cameron JL. Evaluation of prophylactic antibiotics in acute pancreatitis. J Surg Res. 1975;18:197–200.
Finch WT, Sawyers JL, Schenker S. A prospective study to determine the efficacy of antibiotics in acute pancreatitis. Ann Surg. 1976;183:667–71.
Golub R, Siddiqui F, Pohl D. Role of antibiotics in acute pancreatitis: a meta-analysis. J Gastrointest Surg. 1998;2:496–503.
Pederzoli P, Bassi C, Vesentini S, et al. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet. 1993;176:480–3.
Luiten EJ, Hop WC, Lange JF, et al. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg. 1995;222:57–65.
Sainio V, Kemppainen E, Puolakkainen P, et al. Early antibiotic treatment in acute necrotising pancreatitis. Lancet. 1995;346:663–7.
Delcenserie R, Yzet T, Ducroix JP. Prophylactic antibiotics in treatment of severe acute alcoholic pancreatitis. Pancreas. 1996;13:198–201.
Schwarz M, Isenmann R, Meyer H, et al. Antibiotic use in necrotizing pancreatitis. Results of a controlled study. Dtsch Med Wochenschr. 1997;122:356–61.
Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.
Guyatt GH, Sackett DL, Cook DJ, for the Evidence-Based Medicine Working Group. Users’ guides to the medical literature II. How to use an article about therapy or prevention. A. Are the results of the study valid? JAMA. 1993;270:2598–601.
Oxman AD, Cook DJ, Guyatt GH, for the Evidence-Based Medicine Working Group. Users’ guides to the medical literature VI. How to use an overview. JAMA. 1994;272:1367–71.
• Guyatt G, Drummond R, Meade M, et al. Users’ guides to the medical literature: a manual for evidence-based clinical practice. 2nd ed. New York: McGraw-Hill Professional; 2008. This book is a compilation of the Users’ Guides series published in JAMA beginning in 1993. It is an indispensable tool for the reader of medical literature, providing a framework for appraising the quality of published clinical trials and applying them to patient care.
Sharma VK, Howden CW. Prophylactic antibiotic administration reduces sepsis and mortality in acute necrotizing pancreatitis: a meta-analysis. Pancreas. 2001;22:28–31.
Heinrich S, Schafer M, Rousson V, et al. Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg. 2006;243:154–68.
Villatoro E, Bassi C, Larvin M. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev. 2006;4:CD002941.
Mazaki T, Ishii Y, Takayama T. Meta-analysis of prophylactic antibiotic use in acute necrotizing pancreatitis. Br J Surg. 2006;93:674–84.
Xiong GS, Wu SM, Wang ZH. Role of prophylactic antiobiotic administration in severe acute pancreatitis: a meta-analysis. Med Princ Pract. 2006;15:106–10.
Nordback I, Sand J, Saaristo R. Early treatment with antibiotics reduces the need for surgery in acute necrotizing pancreatitis—a single-center randomized study. J Gastrointest Surg. 2001;5:113–8.
Isenmann R, Runzi M, Kron M, et al. (German) Antibiotics in Severe Acute Pancreatitis Study Group: prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology. 2004;126:997–1004.
Spicak J, Hejtmankova S, Cech P, et al. Antibiotic prophylaxis in large pancreatic necrosis: multicenter randomized trial with ciprofloxacin and metronidazole or meropenem. Gastroenterology. 2004;126 Suppl 2:A-229.
Dambrauskas Z, Gulbinas A, Pundzius J, et al. Meta-analysis of prophylactic parenteral antibiotic use in acute necrotizing pancreatitis. Medicina. 2007;43:291–300.
Takeda K, Matsuno S, Ogawa M, et al. Continuous regional arterial infusion (CRAI) therapy reduces the mortality rate of acute necrotizing pancreatitis: results of a cooperative survey in Japan. J Hepatobiliary Pancreat Surg. 2001;8:216–20.
Bassi C, Mangiante G, Falconi M, et al. Prophylaxis for septic complications in acute necrotizing pancreatitis. J Hepatobiliary Pancreat Surg. 2001;8:211–5.
Manes G, Rabitti PG, Menchise A, et al. Prophylaxis with meropenem of septic complications in acute pancreatitis: a randomized, controlled trial versus imipenem. Pancreas. 2003;27:e79–83.
Maravi-Poma E, Gener J, Alvarez-Lerma F, et al. Early antibiotic treatment (prophylaxis) of septic complications in severe acute necrotizing pancreatitis: a prospective, randomized, multicenter study comparing two regimens with imipenem-cilastatin. Intensive Care Med. 2003;29:1974–80.
• de Vries AC, Besselink MGH, Buskens E, et al. Randomized controlled trials of antibiotic prophylaxis in severe acute pancreatitis: relationship between methodological quality and outcome. Pancreatology 2007;7:531–8. This is a well done meta-analysis demonstrating an inverse association between methodologic quality and reported impact of antibiotic intervention on the outcome of mortality in ANP.
• Dellinger EP, Tellado JM, Soto NE, et al. Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. Ann Surg. 2007;245:674–83. This RCT is a high quality study on prophylactic antibiotics for ANP by being double-blind and a relatively large, multicenter trial. It showed no benefit for meropenem on the outcomes of infected necrosis or mortality.
Hart PA, Bechtold ML, Marshall JB, et al. Prophylactic antibiotics in necrotizing pancreatitis: a meta-analysis. South Med J. 2008;11:1126–31.
• Bai Y, Gao J, Zou DW, et al. Prophylactic antiobiotics cannot reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: evidence for a meta-analysis of randomized controlled trials. Am J Gastroenterol. 2008;103:104–10. This is a very well done meta-analysis that stratified validity/quality for its included trials and showed again that only lower quality trials report a benefit for antibiotics. It also contains methodological explanations for why earlier meta-analyses mistakenly found benefit for prophylactic antiobiotics in ANP.
Jafri NS, Mahid SS, Idstein SR, et al. Antibiotic prophylaxis is not protective in severe acute pancreatitis: a systematic review and meta-analysis. Am J Surg. 2009;197:806–13.
Villatoro E, Mulla M, Larvin M. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev. 2010;5:CD002941.
• Bai Y, Gao J, Zou DW, et al. Antibiotics prophylaxis in acute necrotizing pancreatitis: an update. Am J Gastroenterol. 2010;105:705–7. This brief article is an update of their earlier high quality meta-analysis, now containing additional randomized trials and including all three higher quality, double-blinded RCTs. They point out that they now include more patients with a biliary etiology for pancreatitis. This publication represents the most accurate meta-analysis to date of prophylactic antibiotics in ANP.
Xu T, Cai Q. Prophylactic antibiotic treatment in acute necrotizing pancreatitis: results from a meta-analysis. Scand J Gastroenterol. 2008;43:1249–58.
• García-Barrasa A, Borobia FG, Pallares R, et al. A double-blind, placebo-controlled trial of ciprofloxacin prophylaxis in patients with acute necrotizing pancreatitis. J Gastrointest Surg. 2009;13:768–74. This RCT is the newest double-blind study examining prophylactic antibiotics in ANP.
Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
Hennekens CH, DeMets D. The need for large-scale randomized evidence without undue emphasis on small trials, meta-analyses, or subgroup analyses. JAMA. 2009;302:2361–2.
• De Waele JJ. Use of antibiotics in severe acute pancreatitis. Expert Rev Anti Infect Ther. 2010;8:317–24. This article is a descriptive review of this topic, also drawing the conclusion that prophylactic antibiotics are not beneficial in acute necrotizing pancreatitis.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nicholson, L.J. Acute Pancreatitis: Should We Use Antibiotics?. Curr Gastroenterol Rep 13, 336–343 (2011). https://doi.org/10.1007/s11894-011-0198-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11894-011-0198-4